Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Oligonucleotide compound in development for HIV-1 at Sankyo

Oct. 9, 1997

A-74259, an alpha-glucosidase inhibitor isolated from Streptomyces

Oct. 8, 1997

First long-term data for indinavir reported at ICAAC

Oct. 3, 1997

Fortovase compares favorably with Crixivan and Invirase

Oct. 2, 1997

Five efavirenz studies reported at ICAAC

Oct. 2, 1997

Efficacy of Viramune triple drug combination reported at ICAAC

Oct. 2, 1997

Third pivotal trial of VX-478 commences

Oct. 1, 1997

Gene therapy for AIDS in development at Theratechnologies

Oct. 1, 1997

HIV protease inhibitors under development at Vertex

Oct. 1, 1997

Warner-Lambert reports dihydropyrone HIV protease inhibitors

Sep. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...